NTRS
57
2
GIS
28
2
ROP
59
5
JPM
67
4
CINF
51
4
GPC
37
2
ROST
52
5
KLAC
43
4
WDC
43
2
AMP
73
4
NUE
58
7
ACN
49
2
O
22
2
CVX
44
-2
CMS
60
2
M
25
5
NWS
69
7
HOG
33
4
BK
72
4
GLW
46
4
NTRS
57
2
GIS
28
2
ROP
59
5
JPM
67
4
CINF
51
4
GPC
37
2
ROST
52
5
KLAC
43
4
WDC
43
2
AMP
73
4
NUE
58
7
ACN
49
2
O
22
2
CVX
44
-2
CMS
60
2
M
25
5
NWS
69
7
HOG
33
4
BK
72
4
GLW
46
4
Financhill
Back

Dermata Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
20

DRMA
Dermata Therapeutics

Last Price:
1.11
Seasonality Move:
-57.39%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
20
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.15. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 39.31 Sell
Chaikin Money Flow: -22154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.17 - 1.47) Sell
Bollinger Bands (100): (1.3 - 2.18) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Sell
20-day SMA: 1.27 Sell
50-day SMA: 1.45 Sell
200-day SMA: 3.39 Sell
8-day EMA: 1.17 Sell
20-day EMA: 1.26 Sell
50-day EMA: 1.45 Sell
200-day EMA: 6.23 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):